Open AccessStereotactic Body Radiation Therapy (SBRT) for prostate cancer: Preliminary results of toxicity
Author(s) -
A. Naim,
Safae Mansouri,
Kamal Saidi,
Abdeljalil Heddat,
Younes Elhoury,
R. Rabii
Publication year - 2021
Publication title -
archivio italiano di urologia andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.429
H-Index - 23
eISSN - 2282-4197
pISSN - 1124-3562
DOI - 10.4081/aiua.2021.3.370
Subject(s) - prostate cancer , medicine , radiation therapy , prostate , radiobiology , cancer , lung cancer , oncology , radiology , medical physics
To the Editor, Prostate cancer is the second most common cancer in men in Morocco after lung cancer. External radiotherapy (RTE) is a curative therapeutic option for localized prostate cancer, However the conventional RTE remains a long treatment (7- 8 weeks, 5 days a week) which is demanding for patients and make difficult to manage the waiting lists. The development of imaging and irradiation techniques over the last decades has allowed a high precision in the delivery of the dose to the target organ and a better protection of the organs at risk (OAR), which has encouraged the hypo fractionated irradiation of localized prostate cancer, especially after the results of radiobiology studies that suggested a low report a/b for the prostate.